| Date | Ticker | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 28, 2025 | Iridium Communications Inc. | NIEHAUS ROBERT H | buy | 30,000 | $17.49 | $525K |
| Oct 28, 2025 | MapLight Therapeutics, Inc. | Catalyst4, Inc. | buy | 5,441,176 | $17.00 | $92.50M$10M+ |
| Oct 28, 2025 | FFIN👔 FIRST FINANCIAL BANKSHARES INC | Hickox Michelle S EVP/CFO | buy | 2,000 | $31.15 | $62K |
| Oct 28, 2025 | NB Bancorp, Inc. | Pascucci Hope | buy | 4,688 | $18.07 | $85K |
| Oct 28, 2025 | Rein Therapeutics, Inc. | Voss Value Master Fund, LP | buy | 178,392 | $1.39 | $248K |
| Oct 28, 2025 | Burke & Herbert Financial Services Corp. | McLaughlin Shawn Patrick | buy | 1,000 | $61.00 | $61K |
| Oct 28, 2025 | Eastern Bankshares, Inc. | Rivers Robert Francis Executive Chair | buy | 50,000 | $17.21 | $861K |
| Oct 27, 2025 | Origin Bancorp, Inc. | Crotwell Jim Chief Risk Officer | buy | 3,000 | $34.32 | $103K |
| Oct 27, 2025 | Origin Bancorp, Inc. | Moore Preston Chief Credit & Banking Officer | buy | 6,500 | $34.27 | $223K |
| Oct 27, 2025 | Nuvectis Pharma, Inc. | Mosseri Marlio Charles | buy | 72,836 | $6.28 | $457K |
| Oct 27, 2025 | Viking Therapeutics, Inc. | Rowland Charles A Jr | buy | 22,000 | $4.88 | $107K |
| Oct 27, 2025 | Viking Therapeutics, Inc. | Rowland Charles A Jr | buy | 22,000 | $5.80 | $128K |
| Oct 27, 2025 | Viking Therapeutics, Inc. | Rowland Charles A Jr | buy | 16,000 | $4.48 | $72K |
| Oct 27, 2025 | MCB👔 Metropolitan Bank Holding Corp. | Dougherty Daniel F EVP & Chief Financial Officer | buy | 1,000 | $71.66 | $72K |
| Oct 27, 2025 | Rein Therapeutics, Inc. | Voss Value Master Fund, LP | buy | 92,642 | $1.37 | $127K |
| Oct 27, 2025 | KINDER MORGAN, INC. | KINDER RICHARD D Executive Chairman | buy | 1,000,000 | $25.96 | $25.96M$10M+ |
| Oct 27, 2025 | Bridgewater Bancshares Inc | Volk David J. | buy | 13,470 | $17.46 | $235K |
| Oct 27, 2025 | ASIC👔 Ategrity Specialty Insurance Co Holdings | Cohen Justin G Chief Executive Officer | buy | 5,200 | $19.41 | $101K |
| Oct 27, 2025 | Neumora Therapeutics, Inc. | Burow Kristina | buy | 1,915,700 | $2.61 | $5.00M$1M+ |
| Oct 27, 2025 | Neumora Therapeutics, Inc. | ARCH Venture Partners XII, L.P. | buy | 1,915,700 | $2.61 | $5.00M$1M+ |